Trials / Completed
CompletedNCT03270553
A Study to Assess the Effect of Plazomicin on the Pharmacokinetics of Metformin
A Phase 1, Open Label, Randomized, 2-Period, 2-Treatment, Crossover Study to Assess the Effect of Plazomicin on the Pharmacokinetics of Metformin in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Achaogen, Inc. · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is a single-center, Phase 1, open label, randomized, two-sequence, two-period, crossover study to evaluate the drug-drug interaction potential between plazomicin and metformin in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | plazomicin | single intravenous dose |
| DRUG | metformin | single oral dose |
Timeline
- Start date
- 2017-08-31
- Primary completion
- 2017-10-07
- Completion
- 2017-10-07
- First posted
- 2017-09-01
- Last updated
- 2017-10-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03270553. Inclusion in this directory is not an endorsement.